# Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia

> **NCT00202397** · PHASE2 · COMPLETED · sponsor: **S. Andrea Hospital** · enrollment: 40 (actual)

## Conditions studied

- Hereditary Ataxia
- Multiple Sclerosis
- Cerebellar Ataxia

## Interventions

- **DRUG:** Riluzole
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00202397
- **Lead sponsor:** S. Andrea Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-06
- **Final completion:** 2008-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00202397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00202397, "Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00202397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*